Despite a growing body of evidence, the distinct contributions of biological sex and the
sociocultural dimension of gender to the manifestations and outcomes of ischaemic heart …

Sex differences in cardiovascular disease (CVD) are often recognized from experimental
and clinical studies examining the prevalence, manifestations, and response to therapies …

Aims This cohort study intended to elucidate the association between serum uric acid (SUA)
levels and cardiovascular disease events in Japanese patients with obesity. Methods …

Background In this study, we evaluated the lipidome alterations caused by type 1 diabetes
(T1D) and type 2 diabetes (T2D), by determining lipids significantly associated with diabetes …

Background: Patients with primary Sjögren's syndrome (pSS) are at increased risk of
cardiovascular morbidity as compared with the general population. Objectives: A …

Sex differences are consistently identified in determining the prevalence, manifestation, and
response to therapies in several systemic disorders, including those affecting the …

BACKGROUND: Sex differences exist in the likelihood of cognitive decline. The age at
hypertension diagnosis is a unique contributor to brain structural changes associated with …

Historically, lipid panels have been used to predict cardiovascular risk. However, individuals
with well-controlled lipid levels continue to have cardiac events. Recent advances in …

Objective: Findings from studies of the long-term effect of premature menopause on risks of
all-cause mortality in women are equivocal. We used the approach of propensity score …

Significance: Cardiovascular disease is a major contributor to human mortality and
morbidity. The cardiac tissue undergoes fibrotic healing after injury because of the limited …